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Background: Clinical trials data management (CTDM) remains one of the many challenges in running state of the art
trials in resource-poor settings since most trials do not allocate, or have available, sufficient resources for CTDM and
because of poor internet connectivity. Open-source software like OpenClinica could be a solution in such scenarios.
Findings: In 2007, the KEMRI-Wellcome Trust Research Programme (KWTRP) adopted OpenClinica (OC) community
edition, an open-source software system and we share our experience and lessons learnt since its adoption. We have
used OC in three different modes; direct remote data entry from sites through Global System for Mobile Communications
(GSM) modems, a centralized data centre approach where all data from paper records were entered at a central
location and an off-line approach where data entry was done from a copy of database hosted on a field-site server
laptop, then data uploaded to a centralized server later. We have used OC in eleven trials/studies with a cumulative
number of participants in excess of 6000. These include large and complex trials, with multiple sites recruiting in
different regions of East Africa. In the process, we have developed substantial local capacity through hands-on training
and mentorship, which we have now begun to share with other institutions in the region.
Conclusions: Our experience demonstrates that an open source data management system to manage trials’ data can
be utilized to international industry standards in resource-poor countries.
Keywords: Clinical trials, Data management, Open-source systems, OpenClinicaFindings
Introduction-the need for open-source software
Clinical trials are primarily set up to answer specific re-
search questions; answering these research questions en-
tails gathering, storing and processing data. There is a
need to develop stringent strategies of collecting, man-
aging and producing high quality trial data [1]. Data
management is a complex process that involves investi-
gators collecting data directly from the trial participants,
laboratory technician running trial samples, data entry
by data entry clerks, data monitoring, system adminis-
trators maintaining the data within the database and
communicating with trial managers, and analysis by stat-
isticians and study Investigators. Given this complexity,
few trials go exactly as initially planned; in the course of
the trial, case report forms (CRF) may need updating, a* Correspondence: mngari@kemri-wellcome.org
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unless otherwise stated.new trial site may be added and new technology may
emerge. With many clinical trials going global [2], man-
aging all these issues and stakeholders to yield data of
high quality needs a well thought-out plan. All these
complexities notwithstanding, an investigator has to
worry about the cost of acquiring, installing and main-
taining a data management system and compliance with
set guidelines and standards [3].
Historically, trials’ data have been captured on paper
and investigators had to handle large volumes of paper.
However, electronic data capture (EDC) and use of elec-
tronic case report forms (eCRF) are becoming more uti-
lized and have revolutionized the way trial data are
managed [4-6]. The advent of EDC and eCRF has re-
duced the burden of organizing paper CRFs, greatly re-
ducing the time to avail data in electronic formats and
improved the efficiency in running clinical trials [7].
However, these benefits come with some challenges. The
whole process of clinical trial data management using
EDC and eCRF requires substantial capital investment
and utilizing sophisticated technology requiring highlytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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EDCs that are validated to ensure trial data reliability, ac-
curacy, security and electronic audit trails that document
every action on the EDC [10]. In the rapidly changing in-
formation technology environment, careful consideration
is needed before investing in new hardware or software.
And, any EDC system comes with the additional chal-
lenges of installation, customization, configuration or/and
integrating with existing systems such as laboratory or
clinical surveillance systems. For academic institutions,
small-size research institutions, individual investigators
and poorly funded research institutions, particularly from
developing countries, traditional paper based approaches
with data entry at a central location may be the most feas-
ible considering all these factors.
The demand to make clinical trials management af-
fordable whilst still complying with industry standards,
regulatory requirements and best practices continues to
grow. There is need to build conducive environments
that supports flexible trial design, configuration and
quick deployment of robust EDC, real-time data capture,
extraction, analysis and reporting of trials’ findings [10].
This has led to adoption of EDC and e-clinical systems
in clinical trial data management in various research en-
vironments with varying degree of success [11]. We have
previously argued [9] that an open source clinical trial
data-management system could help in achieving the
above targets. Within a short time, the usage of open
source EDC has grown rapidly and, a good example is
OpenClinica (OC) [12]. Adoption of OpenClinica as a
clinical trials’ EDC has grown tremendously since its re-
lease in 2005, currently boasting of over 15,000 commu-
nity members with a presence in over 100 countries
[12]. Open source EDCs are becoming common because
they are free to download and use, come with low/free
cost of maintenance and are easy to install and use. They
can be customized to the requirements of the end-users
since their codes are available freely, can be configured
to the security standards of the user and are interoperable
with existing systems. Open source EDCs have the poten-
tial of increasing and improving public health research ac-
tivities and raising academic standards because of their
availability (they are inexpensive/free) and have a commu-
nity of users and developers, where experience and ideas
are freely exchanged [13-15]. Such exchanges enrich and
reify the source code, improving the EDC’s quality and
leading to additional useful features to the users.
In this article we describe our experience with Open-
Clinica, an open-source EDC in managing clinical trials
data in Kenya and the surrounding region.
How we started
A Clinical Trials Facility (CTF) was setup within KWTRP
because there was a need to have a coordinating centre formultiple trials and develop capacity to manage trials to
standards used in the developed world. For the last
25 years, KWTRP has conducted clinical, laboratory and
epidemiologic research within Kilifi County and its envir-
ons [16]. There was a wide difference between academic
and pharmaceutical or product development trials, and so
the aim was to ensure that all studies had access to moni-
toring, good data management and trial coordination. The
CTF was set up to provide a centralized resource of study
support functions in order that skills and best practice
could be shared between different studies and disease
areas. This worked very well, especially for data manage-
ment where a dedicated data management office was set
up. After careful consideration of resources needed, time,
human capital and international good clinical practice
(GCP) standards, we chose OC as our Clinical Trial Data
management System (CTDMS) [9]. This decision was
followed by a one week on-site training by the developers
of OC, Akaza Research LLC, in mid 2007. No external sys-
tem validation was done, however, we internally validated
the initial version to meet the GCP requirements, and
have continuously validated all updated versions before
use. Later an in-house ‘OC group’ was set up to champion
and oversee implementation of the system. The group
comprised the heads of CTF and Statistics department,
data managers, a system administrator and other stake-
holder (lead PI). The group held regular meetings through
which targets were set, learning tasks appointed, experi-
ences shared and progress reviewed.
Up to the present date, we have maintained a system
administrator offering technical support to the users
while individual trial instances are designed and man-
aged by specific data managers. The initial system ad-
ministrator had a Bachelors level degree in Computer
Science with skills in programming and databases and
worked within the ICT department spending no more
than 5% of their time on OC. The data managers come
from a diverse range of academic backgrounds (Statistics,
IT, Biological Sciences) and are hired directly for specific
trial teams but sit as a pool within CTF allowing for shar-
ing of ideas and experience, thus fostering consistency in
how KWTRP runs trials.
Our computing environment
We configured OC on a server running Windows Server
2003 operating system and using an Apache Tomcat ap-
plication server and a PostgreSQL database. In line with
KWTRP IT standards, the software and database have
been installed on separate servers to ensure greater se-
curity, manageability, and flexibility. To add further data
security the OpenClinica software and PostgreSQL data-
base were integrated with the Programme’s Microsoft
Active Directory based, central user access and manage-
ment system.
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‘private cloud’ infrastructure that is based on Microsoft
Hyper-V virtualisation, HP Blade hardware, NetApp
storage, and within our Internet Service Provider (ISP)’s
wide area network. Implementing the solution within
this environment provides the following features; data-
base backup every 15 minutes, ability to deliver the ser-
vice from either Kilifi or Nairobi office, ability to recover
the service anywhere in the cloud within 30 minutes.
However, one is able to run OC on a much smaller spe-
cified environment, which meets the following criteria
as specified by the developers, Akaza Research LLC in
Table 1 [12].
System security
Security in OC is ensured through use of usernames and
passwords to authenticate users and provision of differ-
ent privilege levels to users based on their roles that are
specified by a system administrator. For example clinical
monitors and data specialists (statisticians/data analyst)
have read only rights; they cannot edit data in the data-
base. Additionally the system requires the investigator or
designated member to electronically sign the partici-
pants’ records data before database lock. Such elec-
tronically signatures are legally binding and make theTable 1 OpenClinica system requirements adopted from the d
system-requirements) [12]
Version Server OS Database Application server L




Red Hat Enterprise Tomcat 6.0.32
Linux 4.0
CentOS Ubuntu Oracle 10











Postgres 8.4 Apache Tomcat 7.0X J
Windows 2003






Postgres 8.4 Apache Tomcat 7.0X J
Windows 2003
R2 or above 32-bit
Ubuntu 12.04
LTS 64-bitinvestigators take full responsibility of ensuring the elec-
tronic data are complete and accurate.
Within KWTRP, we implemented additional security
by installing the database and the application on differ-
ent servers. A demilitarized zone (DMZ) was created for
further security since the OpenClinica server was re-
quired to be publicly accessible. The DMZ is a logical
sub-network in which publicly accessible servers are
placed. This ensures that in case the publicly accessible
server is compromised, the attacker is not able to reach
other servers in the internal network. We also imple-
mented SSL (Secure Socket Layer), a security protocol
that ensures data submitted on the internet is encrypted
and secure from eavesdropping.
Our successful implementation of different OC modes
For the last five years that we have been using OpenClinica,
we have run eleven clinical trials ranging from phase I-III,
involving in excess of 6000 study participants. We have
used it in three different modes; direct remote data entry
from sites using GSM modems, a centralized data centre
approach where facsimiles of all paper records were sent
and data entered and an off-line approach where data
entry was done from a copy of database hosted on a field-
site server installed on a laptop and the data uploaded onevelopers (https://docs.openclinica.com/installation/
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day.
Technically, we have been able to install and run OC
within our computing environment without having to
incur extra expense of new software. Being a web-based
system, we have used it extensively to run our multisite
studies with the database hosted at our centre in Kilifi
and being accessed for data entry, monitoring and ex-
traction from our various sites or collaborators’ centres.
Internet access in Kenya is readily available via GSM
modems supported by telecommunication companies ei-
ther through post-paid or pre-paid tariffs. We have man-
aged a near real-time data entry from the sites of one
large multisite study (case study 2) making data available
to researchers promptly. The study sites used GSM mo-
dems to access the system, meaning we used the internet
only during data entry keeping the cost of running the
study minimal. Data from one of the study (case study
1) was extracted by a study statistician at the UK’s
Medical Research Councils’ Clinical Trials Unit (MRC-
CTU) in London. At CTF, we have a pool of clinical
monitors electronically monitoring various studies using
OC, these include studies from East Africa region that
we offer clinical monitoring services. Most of these stud-
ies’ data are accessed remotely at CTF by the clinical
monitors. This way, we have been able to manage near
real-time data entry from remote sites, made data avail-
able to a statistician remotely from distant parts of the
world and offer electronic clinical monitoring to many
studies within the region.
Where we conducted trials in areas with erratic power
supply or internet connectivity, we adopted an offline
strategy as had been done by others in such settings
[17]. A replica of the main OC database running on
the server at Kilifi centre was installed on one laptop
which acted as a “field server”. The field server was
configured to create a wireless network to connect with
two data entry client laptops in the field. Data entry
was then done from the client laptops with the data
being saved on the field server. Automatic backups to
an external hard disk, was set to run after every two
hours. At the pre-set timepoints, a database dump
script was ran on the field server to produce a database
file which was then copied to the live server at KWTRP
data centre.
Studies
Table 2 details the studies that we have carried out using
the OC platform. The way these have been implemented
using this system varied given limitations or constraints
of available technology, staff and connectivity in the sites
where we implemented these studies. We highlight three
use cases based on studies that used different modes of
using OC as shown in Table 3.Case study 1: FEAST (Fliud Expansion as a Supportive Therapy)
FEAST was a randomised, open-label clinical trial that
tested the safety and efficacy of giving rapid fluid resus-
citation compared with no bolus (control) in severely ill
hospitalized children (ISRCTN: 69856593). The trial was
conducted in six hospitals in East Africa: four hospitals
in Uganda and one hospital in each of Kenya and
Tanzania, running from January 2009 to April 2011.
Paper CRF elements were transcribed from source docu-
ments and 100% study monitoring/verification done for
a subset of selected data items. Due to limited internet
connectivity at some of the sites, data entry could not be
done directly, thus paper CRFs were sent by courier ser-
vice to the central data centre in Kilifi from where data
entry was done. Data queries were resolved through data
query forms sent by the data manager to the study sites
through email. The data was later extracted for analysis
by a statistician based at the UK’s Medical Research
Councils’ Clinical Trials Unit (MRC-CTU) in London.
The study result was published in 2011 [21].
Case study 2: CTX (Cotrimoxazole prophylaxis)
CTX was a randomised, double blind, placebo-controlled
trial with the primary objective of determining the efficacy
of cotrimoxazole prophylaxis in reducing post-discharge
mortality among hospitalized, HIV-uninfected but severely
malnourished children (NCT00934492). The trial re-
cruited participants from four district hospitals distributed
across Kenya with three sites at the Coast and one in
Nairobi. OC was setup and managed at the Kilifi data
centre. At least two field workers (field staff with second-
ary education) were trained to enter the data at each site
and the application was accessed directly from sites using
GSM modems connected to the internet. Each site only
had access to their respective data and data entry was
done at near real time once the paper CRFs had been
completed. Study data was automatically extracted once a
week, and imported into Stata (Stata Corp, College Sta-
tion, TX USA). Data quality was ensured through reso-
lution of queries raised by electronic monitoring, having
100% source data verification, validation checks set in the
database and checks run on the extracted data. The study
completed data collection at the end of March 2014 but is
yet to publish results (expected late 2014).
Case study 3: TRAPVAC 046 (Thrombospondin-related
adhesion protein vaccine 46th trial)
TRAPVAC 046 was the locally used acronym for a single
blinded controlled phase IIb trial that assessed the effi-
cacy of a heterologous prime-boost vaccine strategy with
ChAd63 ME-TRAP and MVA ME-TRAP in healthy
adults in Kenya (NCT01666925). This small study, with
a sample size of 120 participants, recruited healthy men,
18–50 years old, residing within Kilifi county where
Table 2 Inventory of studies carried out to date using OpenClinica




Methotrexate Mar–Aug 2009 NCT00791531 1 site Chilengi
et al. [20]
http://clinicaltrials.gov/show/NCT00791531 25 participants
FEAST Jan 2009-Jan 2011 ISRCTN69856593 6 sites Maitland
et al. [21]
www.controlled-trials.com/isrctn/pf/69856593 3141 participants
MODMAL* Apr – Oct 2009 NCT00890695 1 site
http://clinicaltrials.gov/ct2/show/NCT00890695 400*
CTX Nov 2009 – Mar 2014 NCT00934492 4 sites
http://clinicaltrials.gov/show/NCT00934492 1781 participants
PUFA/Njugu Plus May2012-May2013 NCT01593969 1 site
http://clinicaltrials.gov/ct2/show/NCT01593969 60 participants
TRAP VAC Jun 2010-May2011 NCT01379430 1 site Ogwang C
et al. [22]
http://clinicaltrials.gov/show/NCT01379430 30 participants
VAC 046 Mar-Aug 2012 NCT01666925 1 site
http://clinicaltrials.gov/ct2/show/NCT01666925 120 participants
CATMAP Apr 2011-Nov 2012 NCT01190371 1 site
http://clinicaltrials.gov/show/NCT01190371 175 participants
MESALAMINE June2013-April 2014 NCT01841099 1 site Jones
et al. [23]
http://clinicaltrials.gov/show/NCT01841099 44 participants
EAPHLNP April-July 2013 NCT01899820 7 sites
http://clinicaltrials.gov/ct2/show/study/NCT01899820 352 Participants
(Kwale Site only)






*Stopped early due to lack of study participants only 64 recruited of 400 target.
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paper CRFs directly at the field site by both clinicians
and data entry staff on laptops connected to the field
server. A wireless local area network connected the add-
itional laptops to the field server. At the end of each
day, a copy of the database on the field server was
uploaded to the main OC server in the data centre. Elec-
tronic monitoring and data extraction were done from
this main/centralized OC server by the study monitors
and statistician respectively. The study completed data
collection but is yet to publish its results.
Capacity strengthening
We have held training within and outside Kenya and
hosted a number of data managers from other institu-
tions interested in learning and using OC as shown in
Table 4. Most recently we have been consulted by in-
vestigators of an Ethiopian intervention study against
Podoconiosis [18] starting in 2014 for trial management,
statistics, data monitoring and management using OC.We have participated in several workshops and confer-
ences presenting our experience using OC, including
the OpenClinica Global Conference of 2010 and sixth
European & Developing Countries Clinical Trials Part-
nership (EDCTP) Forum in Addis Ababa, Ethiopia. The
data management group in KWTRP actively participates
in the Global Health Trials (www.globalhealthtrials.org)
which is a free resource to support clinical trials con-
ducted in resource limited settings. Through this we have
supported and advised many diverse groups in the use of
OC and other data management queries. Amongst other
things, we provided training to fellow researchers from the
East African region working at Amnauer Hansen Research
Institute, Ethiopia, Uganda Viral Research Institute, Uganda
and Mwanza Intervention Trials Unit, Tanzania (Table 4).
Challenges and future plans
Due to the web-based nature of OC, remote access to
the database requires a network connection. This poses
a challenge for real time data entry as some study sites
Table 3 Details of exemplar case studies
Study name & approximate
database size (Mb)
Description data of distinct CRF
(# of data items)
Number of events Method of OC deployment
FEAST (32) 10 events Data centre approach that collated, entered
and managed all inputs from six study
sites at centralised locationEnrolment (29) Enrolment (×1)
Clinical information (243) Clinical information (×2)
Additional Assessments (74) Additional assessments (×3)
Serious Adverse Events (31) Serious Adverse Events (×1)
Follow up (34) Follow up (×3)
CTX (12) 7 events Data entered into the centralised system
directly from the four study sites
Enrolment (71) Enrolment
Discharge Information (21) Discharge
Follow ups (198) Follow ups (×9)
Study conclusion (12) Study conclusion
Adverse Events (13) Adverse Event
Serious Adverse Events (14) Serious Adverse Event
Concomitant medication (28) Concomitant medication
TRAPVAC 046 (5.5) 26 events Field based laptop server with two
data entry clients
Screening (119) Screening
Pre-vaccinations check (80) Pre-vaccinations (×2)
Vaccines administration (20) Vaccine administration (×2)
Systemic Adverse Event (126) Systemic Adverse Event (×2)
Follow ups (180) Follow ups (×6)
Concomitant Medication (7) Concomitant medication
Adverse Event (15) Adverse Event
Serious Adverse Event (7) Serious Adverse Event
End of study (3) Unscheduled Visit
End of study
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connectivity; however we have found modalities to work
around this as discussed in one of the case studies above.
Initial problems of sluggish response times and system
timeouts were ameliorated through adjustment of mem-
ory allocation to Tomcat (See http://tomcat.apache.org/)
and reducing the application logging levels. XML rules
were found to adversely affect the application’s response
time and therefore other options for data quality assuranceTable 4 Details of trainings conducted
Institution/group Dates
Annauer Hansen Research Institute, Ethiopia (2 pers) and
MRC/UVRI Uganda (1 pers), 3 data managers
May to July
Mwanza Intervention Trials Unit (MITU), 1 data manager March to Ju
MRC/UVRI, statistician and data management staff with
staff from MITU also attending (approx 10 participants)
February 20
KWTRP, data entry staff November
KWTRP, internal monitors March 2010such as post data-entry validation using statistical pack-
ages and CRF based validation were explored and used.
Help and insights to solve such problems was found by re-
ferral to OpenClinica online wikibooks-based user manual
[19] and other online information shared by the user com-
munity, such as the electronic discussions forums.
As technology evolves, we will link OC with other
existing system such as the laboratory and clinical data
systems at KWTRP. We will extend the “Extract Data”Details
2012 The trainees spent two months at KWTRP learning from
experienced system users.
ne 2011 The trainee spent four months at KWTRP learning from
experienced system users.
11 A one week training covering full details of installation
and system use.
2010 A one day refresher training for data entry staff.
A one day training of trial monitors to conduct
electronic monitoring.
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ages such as Stata which is the statistical lingua franca
at KWTRP. We are also keen on using phones and tab-
let devices for direct data capture. We are yet to discard
paper based primary CRFs and do direct data capture at
trial sites but aim to do this in future trials.Conclusion
Our five years’ experience shows it’s possible to use OC
successfully in different trials employing different EDC
infrastructures in resource-poor environments. Working
as a team involving investigators, trial managers, clinical
monitors, data managers, system administrators and
statisticians from the onset of the system selection, in-
stallation, training and use was a key driver to successful
implementation of the OC system in our institution.
Adoption of an open-source CTDM system remains a
promising solution to data management of multisite tri-
als, especially in low resource settings.Availability and requirements
Project name: OpenClinica.
Project home page: https://www.openclinica.com/.
Operating system(s): Linux, Windows.
Programming language: Java, PostgreSQL/Oracle.
Other requirements: Apache Tomcat, Web browser for
example Internet Explorer or Mozilla Firefox.
Any restrictions to use by non-academics: None (GNU
Lesser General Public License).
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